Drugs / DE-108
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02573610 | Sep 2015 → Mar 2017 | cataract | Santen Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DE-108 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02573610 ↗ |
| Route | Other | “DE-108 ophthalmic solution” NCT02573610 ↗ |